MultiPlan (NYSE: MPLN)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-04 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.040 | 0.070 | 0.0300 | ||||
REV | 283.720M | 298.046M | 14.326M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of MultiPlan (NYSE: MPLN) through any online brokerage.
Other companies in MultiPlan’s space includes: Change Healthcare (NASDAQ:CHNG), GoodRx Holdings (NASDAQ:GDRX), OptimizeRx (NASDAQ:OPRX), Pear Therapeutics (NASDAQ:PEAR) and Definitive Healthcare (NASDAQ:DH).
The latest price target for MultiPlan (NYSE: MPLN) was reported by Citigroup on Wednesday, May 11, 2022. The analyst firm set a price target for 6.50 expecting MPLN to rise to within 12 months (a possible 9.06% upside). 4 analyst firms have reported ratings in the last year.
The stock price for MultiPlan (NYSE: MPLN) is $5.9601 last updated Today at June 28, 2022, 4:10 PM UTC.
There are no upcoming dividends for MultiPlan.
MultiPlan’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for MultiPlan.
MultiPlan is in the Health Care sector and Health Care Technology industry. They are listed on the NYSE.